Best Agrolife Ltd

Best Agrolife Ltd

₹ 615 0.11%
23 Jul - close price
About

Best Agrolife (formerly known as Sahyog Multibase Limited) [1] is a leading agrochemicals manufacturer in India and is among the top 15 agrochemicals companies in the country. It is one of the fastest growing manufacturers of Technicals, Formulations, Intermediates and Public Health products. Best Agrochem Private Limited was amalgamated with the Co. in April 2018.

It offers more than 70 Formulations in the form of Insecticides, Herbicides, Fungicides and Plant Growth Regulators, which are developed from active ingredients manufactured in-house. As part of its P2P set-up, Best Agrolife caters to several blue-chip corporates and leading MNCs from India and abroad. [2]

Key Points

Product Portfolio
The Co has three business activities namely, Technical, Formulation, and Branded Products. [1]
The product profile includes insecticides, pesticides, herbicides, plant-growth regulators (PGR) and biocides. As of Q2FY24, it has licence of 250+ formulations registered with Central Insecticide Board (CIB), PGRs and bio fertilizers. As of FY23, it has 60+ products, 80+ technical licenses, 360+ formulation licenses.Some of its best selling products are DIRON, PYMAX, PYDON, IRMA, etc. [2] It launched key products like RONFEN, AXEMAN, REVEAL, CITIGEN, and VISTARA. [3][4]

  • Market Cap 1,453 Cr.
  • Current Price 615
  • High / Low 1,374 / 454
  • Stock P/E 13.7
  • Book Value 274
  • Dividend Yield 0.49 %
  • ROCE 16.5 %
  • ROE 18.1 %
  • Face Value 10.0

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 32.3%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
208 345 324 232 309 464 700 328 254 612 811 314 135
171 308 289 200 247 398 518 270 247 482 667 296 202
Operating Profit 37 36 35 32 62 66 183 58 7 130 144 19 -67
OPM % 18% 10% 11% 14% 20% 14% 26% 18% 3% 21% 18% 6% -50%
1 1 0 -0 1 0 1 1 1 4 -3 1 1
Interest 2 1 2 5 7 7 9 10 13 12 15 19 15
Depreciation 1 1 1 3 7 6 6 6 7 7 8 6 11
Profit before tax 35 35 33 23 49 53 168 43 -12 115 118 -6 -92
Tax % 27% 26% 24% 34% 23% 25% 23% 29% -28% 21% 19% 3% -22%
25 26 25 15 38 40 130 31 -8 90 95 -7 -72
EPS in Rs 11.47 11.77 11.43 6.55 16.14 16.97 54.90 12.95 -3.56 38.27 40.12 -2.80 -30.66
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024
127 151 905 1,211 1,746 1,873
126 154 854 1,045 1,432 1,648
Operating Profit 1 -2 51 166 314 226
OPM % 0% -1% 6% 14% 18% 12%
1 4 7 2 3 3
Interest 1 2 5 15 39 62
Depreciation 0 0 3 12 24 33
Profit before tax 0 0 51 141 253 134
Tax % 575% 100% 27% 26% 24% 21%
-0 0 37 105 192 106
EPS in Rs -0.65 0.03 16.83 44.31 81.27 44.94
Dividend Payout % 0% 798% 12% 5% 4% 7%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 27%
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 42%
TTM: -45%
Stock Price CAGR
10 Years: %
5 Years: 59%
3 Years: 10%
1 Year: -47%
Return on Equity
10 Years: %
5 Years: %
3 Years: 32%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 8 8 22 24 24 24
Reserves 46 48 108 306 504 623
0 19 33 270 568 637
63 35 209 384 380 730
Total Liabilities 117 110 372 984 1,475 2,013
0 0 19 180 203 362
CWIP 0 0 4 5 14 15
Investments 32 3 0 0 0 0
85 107 349 800 1,258 1,636
Total Assets 117 110 372 984 1,475 2,013

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-14 -41 13 -60 -180 36
-34 31 8 -15 -19 -63
48 10 -11 67 248 -1
Net Cash Flow 0 -0 10 -8 49 -29

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 85 87 53 77 73 91
Inventory Days 67 199 391 247
Days Payable 72 124 167 149
Cash Conversion Cycle 85 87 48 152 297 189
Working Capital Days 61 175 43 117 157 162
ROCE % 0% 41% 34% 16%

Shareholding Pattern

Numbers in percentages

4 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
40.78% 45.42% 45.42% 47.30% 47.30% 48.20% 50.10% 50.10% 50.10% 50.10% 50.10% 50.10%
11.55% 11.22% 11.31% 10.82% 11.27% 12.05% 11.48% 10.84% 9.86% 8.86% 8.77% 8.73%
0.23% 0.19% 0.20% 0.20% 2.57% 2.57% 2.58% 2.55% 2.63% 2.53% 2.53% 2.53%
47.44% 43.17% 43.08% 41.68% 38.86% 37.16% 35.84% 36.50% 37.42% 38.50% 38.60% 38.62%
No. of Shareholders 3,3134,9528,2258,76011,36021,20623,03927,20031,94037,57139,86141,570

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents